loader
Please Wait
Applying Filters...
menu
    • menu

    Digital Content for Methyl Testosterone

    Client Email Product
    Polpharma is a Polish CDMO of APIs and a significant European API producer, delivering products to companies worldwide.

    Virtual Booth

    Contact Supplier

    Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-09-09

    Virtual Booth

    Contact Supplier

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-09-09

    Virtual Booth

    Contact Supplier

    Menu

    Methyl Testosterone

    ACTIVE PHARMA INGREDIENTS

    PRICE INFORMATION

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 1,186Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    ECI Pharmaceuticals Receives FDA Warning Letter
    ECI Pharmaceuticals Receives FDA Warning Letter

    23 Mar 2022

    // FDA

    https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/eci-pharmaceuticals-llc-625254-02032022-0

    FDA
    23 Mar 2022
    Share Share
    Novitium Pharma's Generic Methyltestosterone Receives Approval in the U.S.
    Novitium Pharma's Generic Methyltestosterone Receives Approval in the U.S.

    18 Feb 2022

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215270

    FDA
    18 Feb 2022
    Share Share
    Enforcement Report - Week of July 10, 2019
    Enforcement Report - Week of July 10, 2019

    10 Jul 2019

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-july-10-2019-1562736086.pdf

    FDA
    10 Jul 2019
    Share Share
    Enforcement Report - Week of January 23, 2019
    Enforcement Report - Week of January 23, 2019

    23 Jan 2019

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-january-23-2019-1548227584.pdf

    FDA
    23 Jan 2019
    Share Share
    Impax Labs' Generic Methyltestosterone (10mg) approved in US for Hypogonadism (low-T)
    Impax Labs' Generic Methyltestosterone (10mg) approved in US for Hypogonadism (low-T)

    23 Sep 2015

    // FDA

    https://www.pharmacompass.com/pdf/news/impax-labs-generic-methyltestosterone-10mg-approved-in-us-for-hypogonadism-low-t-1443180115.pdf

    FDA
    23 Sep 2015
    Share Share
    Impax Receives FDA Approval for Generic Version of Testred® C-III
    Impax Receives FDA Approval for Generic Version of Testred® C-III

    22 Sep 2015

    // PR NEWS WIRE

    http://www.prnewswire.com/news-releases/impax-receives-fda-approval-for-generic-version-of-testred-c-iii-methyltestosterone-capsules-usp-10-mg-300146791.html

    PR NEWS WIRE
    22 Sep 2015
    Share Share